23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...

Yesterday afternoon the FDA announced that it would permit 23andMe to market its Personal Genome Service Pharmacogenetic Reports test. The test offers consumers information on whether they posses one ...

PALO ALTO, Calif. - November 20, 2025 - For millions of Americans in the African diaspora, genealogical ties and records were severed by the transatlantic slave trade, creating a "brick wall" for ...

23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m. As part of a court-supervised sale, the auction will see Regeneron acquire the ...